pharmaceutical investing Coherus BioSciences Announces Positive Topline 24-Week Treatment Phase Three Results for CHS-1420 (HUMIRA® Biosimilar Candidate) in Patients with Psoriasis
Coherus Announces Positive Phase 2b Efficacy Data on Novel Oral Therapy in Relapsing Remitting Multiple Sclerosis
Riverside Resources and Questcorp Complete Geophysics Programs and Continue Drilling at La Union Project
Questcorp and Riverside Resources Complete Complementary Geophysics Programs as Drilling Continues at La Union Project
